COGT · Cogent Biosciences, Inc. · Share Buybacks
Market Cap
$6.12B
Shares
173.52M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-05-06 | 2025-11-07 | $400,000,000 | $88,600,000 as of 2026-06-30 | — | 8-K , filed 2026-08-10 |
Key facts
CIK
1622229
CUSIP
19240Q201
13F (30d)
237 filings
236 filers
Visit website
Investor relations